Multicentric breast carcinoma: Evaluation of clinicopathological and immunohistochemical characteristics
Koji Arihiro(Hiroshima University Hospital), Kouki Inai(Hiroshima University), Shinichi Suehiro(Hamari Chemicals (Japan)), Mayumi Kaneko(Hiroshima City Asa Citizens Hospital), Shinpei Takeda(Hiroshima University), Kanji Kurihara(Hiroshima University), Atsushi Yamamoto(Hiroshima University), Tetsuya Toge(Hiroshima University), Katsumasa Kuroi
Cited by 1
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer
|Cancer Research|2009|291
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Increases of Amphiregulin and Transforming Growth Factor-α in Serum as Predictors of Poor Response to Gefitinib among Patients with Advanced Non–Small Cell Lung Cancers
|Cancer Research|2005|192
Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer
|Clinical Cancer Research|2007|188